Amid growing concerns over declining public support and government backing for cancer research, the recent advocacy event provided a significant platform for addressing these challenges. Gathered at a pivotal conference, key figures from the cancer research community, including renowned scientists
How much could life change for those living with severe skin diseases like recessive dystrophic epidermolysis bullosa (RDEB)? An estimated 200,000 people worldwide confront the daunting challenges of epidermolysis bullosa, a rare inherited disorder that leads to fragile skin and painful wounds.
The world of U.S. biomedical research faces formidable challenges as budget cuts pose a graver risk to scientific progress than ever before. A startling revelation in the form of financial reductions has left many researchers questioning the future of some of the nation’s most critical medical a
Faisal Zain is a healthcare expert specializing in medical technology. He has extensive experience in the manufacturing of medical devices used for diagnostics and treatment, driving innovation in the field. David Wainson engages him in a discussion about the recent closure of the CDC's STD
Surrey, British Columbia, has experienced significant transformation over the past few years. Emerging as a crucial center for biotechnology and health technology, the city has strategically positioned itself as a burgeoning hub for health and life sciences. The concerted efforts of government and
DHL Group, the world's leading logistics provider, made a strategic move by acquiring CRYOPDP, a specialty courier focused on clinical trials, biopharma, and cell and gene therapies. This acquisition aims to bolster DHL's "Health Logistics" division by leveraging CRYOPDP's
